1. Home
  2. ASPS vs CING Comparison

ASPS vs CING Comparison

Compare ASPS & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Altisource Portfolio Solutions S.A.

ASPS

Altisource Portfolio Solutions S.A.

HOLD

Current Price

$6.76

Market Cap

70.7M

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$5.07

Market Cap

64.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPS
CING
Founded
1999
2012
Country
Luxembourg
United States
Employees
N/A
14
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.7M
64.6M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
ASPS
CING
Price
$6.76
$5.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$8.00
$34.50
AVG Volume (30 Days)
20.8K
445.0K
Earning Date
04-23-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
112.00
N/A
EPS
N/A
N/A
Revenue
$942,213,000.00
N/A
Revenue This Year
$9.17
N/A
Revenue Next Year
$24.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$3.20
52 Week High
$15.96
$11.89

Technical Indicators

Market Signals
Indicator
ASPS
CING
Relative Strength Index (RSI) 49.91 42.33
Support Level $6.06 $4.94
Resistance Level $7.37 $5.54
Average True Range (ATR) 0.45 0.44
MACD 0.01 0.04
Stochastic Oscillator 55.22 48.60

Price Performance

Historical Comparison
ASPS
CING

About ASPS Altisource Portfolio Solutions S.A.

Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: